There are a number of types of research agreements that investigators at the Child & Family Research Institute might enter into:
Clinical Trial Agreement
-
Involves patient interaction, and is service-oriented.
-
Includes all phases from development to post-marketing trials.
-
Can be industry-sponsored or investigator-initiated.
|
| |
Industry-Sponsored Clinical Trial Agreement
Anita Chiu
Director, Finance
Phone: (604) 875-2488
Email: achiu@cw.bc.ca
Investigator-Initiated Clinical Trial Agreement
Yasmin Diaz
Manager, Clinical Research Agreements
Phone: (604) 827-5025
Email: yasmin.diaz@uilo.ubc.ca
Confidentiality/Non Disclosure Agreement
Protects confidentiality of certain information that is to be disclosed to a party.
Anita Chiu
Director, Finance
Phone: (604) 875-2488
Email: achiu@cw.bc.ca
Cooperative Research and Development Contract
- Work to be done is jointly defined by the sponsor and the university.
-
Specific results or developments are expected.
|
| |
Yasmin Diaz
Manager, Clinical Research Agreements
Phone: (604) 827-5025
Email: yasmin.diaz@uilo.ubc.ca
Grant in Aid Agreement
- Provides support for the general research activities of an investigator.
-
Investigator defines the scope of work, and has unrestricted control over how funds are spent within the agreed budget.
|
| |
Nataliya Karpenko
Industry Grants Officer
Phone: (604) 822-0892
Email: nataliya.karpenko@uilo.ubc.ca |
Government/Granting Agency Sponsored Contract
Is funded by any government agency, non-profit agency or any other educational institution inside or outside of Canada.
Adriana Suarez-Blanch
Government Contracts Manager
Phone: (604) 822-8583
Email: adriana.suarez-blanch@uilo.ubc.ca
Invention Disclosure (Technology Transfer) Agreement
Concerns commercialization of research and licensing of technology to companies.
Jennifer Lynett
Technology Transfer Manager
Phone: (604) 827-5351
Email: jennifer.lynett@uilo.ubc.ca
Material Transfer Agreement
Is required whenever material (any chemical compounds or any form of biological materials, such as cultures, cell lines, plasmids, nucleotides, proteins, transgenic animals or plants, or pharmaceuticals) is being transferred from a provider to a recipient.
Andrea Sum
(On leave. Replacement: Nandota Chowdeiry)
MTA Administrator
Phone: (604) 822-8020
Email: andrea.sum@uilo.ubc.ca
| Service Agreement |
- Is service-oriented, but involves no patient interaction.
-
Is evaluative (analytical, testing, other services); specific work to be done is defined by sponsor.
|
| |
Nataliya Karpenko
Industry Grants Officer
Phone: (604) 822-0892
Email: nataliya.karpenko@uilo.ubc.ca
Last updated:
10/13/2009
|
